Seminars in Hematology
Volume 41, Issue 4 , Pages 297-302 , October 2004

New paradigms for gene transfer: RNA trans-splicing and small interfering RNA as therapeutic strategies

  • Christopher E. Walsh

      Affiliations

    • Division of Hematology-Oncology, Mount Sinai School of Medicine, New York, NY
    • Corresponding Author InformationAddress correspondence to Christopher E. Walsh, MD, PhD, Division of Hematology-Oncology, Mount Sinai School of Medicine, One Gustave Levy Place, Box 1079, New York City, NY 10029

References 

  1. Abbas-Terki T , Blanco-Bose W , Deglon N , Pralong W , Aebischer P . Lentiviral-mediated RNA interference . Hum Gene Ther . 2002;13:2197
  2. Kowalski J , Derbyshire V . Characterization of homing endonucleases . Methods . 2002;28:365
  3. Sazani P , Kole R . Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing . J Clin Invest . 2003;112:481
  4. Murphy WJ , Watkins KP , Agabian N . Identification of a novel Y branch structure as an intermediate in trypanosome mRNA processing (Evidence for trans splicing) . Cell . 1986;47:517
  5. Rajkovic A , Davis R , Simonsen J , Rottman F . A spliced leader is present on a subset of mRNAs from the human parasite Schistosoma mansoni . Proc Natl Acad Sci USA . 1990;87:8879
  6. Caudevilla C , Serra D , Miliar A , Codony C , Asins G , Bach M , et al.   Natural trans-splicing in carnitine octanoyltransferase pre-mRNAs in rat liver . Proc Natl Acad Sci USA . 1998;95:12185
  7. Finta C , Zaphiropoulos P . Intergenic mRNA molecules resulting from trans-splicing . J Biol Chem . 2002;277:5882
  8. Romani A , Guerra E , Trerotola M , Alberti S . Detection and analysis of spliced chimeric mRNAs in sequence databanks . Nucleic Acids Res . 2003;31:e17
  9. Labrador M , Corces V . Extensive exon reshuffling over evolutionary time coupled to trans-splicing in Drosophila . Genome Res . 2003;13:2220
  10. Bi L , Lawler AM , Antonarakis SE , High KA , Gearhart JD , Kazazian HH . Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A . Nat Genet . 1995;10:119
  11. Liu X , Jiang Q , Mansfield SG , Puttaraju M , Zhang Y , Zhou W , et al.   Partial correction of endogenous DeltaF508 CFTR in human cystic fibrosis airway epithelia by spliceosome-mediated RNA trans-splicing . Nat Biotechnol . 2002;20:47
  12. Puttaraju M , Jamison S , Mansfield S , Garcia-Blanco M , Mitchell L . Spliceosome-mediated RNA trans-splicing as a tool for gene therapy . Nat Biotechnol . 1999;17:246
  13. Puttaraju M , DiPasquale J , Baker CC , Mitchell LG , Garcia-Blanco MA . Messenger RNA repair and restoration of protein function by spliceosome-mediated RNA trans-splicing . Mol Ther . 2001;4:105
  14. Dallinger G , Puttaraju M , Mitchell LG , Yancey K , Yee C , Klausegger A , et al.   Development of spliceosome-mediated RNA trans-splicing (SMaRT) for the correction of inherited skin diseases . Exp Dermatol . 2003;12:37
  15. Garcia-Blanco M . Messenger RNA reprogramming by spliceosome-mediated RNA trans-splicing . J Clin Invest . 2003;112:474
  16. Otto E , Temple G , McGarrity G . Re-programming gene expression using SMaRT . Curr Drug Discovery . 2003;?:37
  17. Chao H , Mansfield SG , Bartel RC , Hiriyanna S , Mitchell LG , Garcia-Blanco MA , et al.   Phenotype correction of hemophilia A mice by spliceosome-mediated RNA trans-splicing . Nat Med . 2003;9:1015
  18. Kolkman J , Stemmer W . Directed evolution of proteins by exon shuffling . Nat Biotechnol . 2001;19:423
  19. Mansfield S , Kole J , Puttaraju M , Yang C , Garcia-Blanco M , Cohn J , et al.   Repair of CFTR mRNA by spliceosome-mediated RNA trans-splicing . Gene Ther . 2000;7:1885
  20. Tahara M , Hackett N , Pergolozzi R , Crystal R . Trans-splicing-mediated CD40-ligand gene therapy correction of a murine model of correction human X-linked immunodeficiency disease . Mol Ther . 2003;7:S154
  21. Pergolizzi R , Ropper A , Dragos R , Reid A , Nakayama K , Tan Y , et al.   In vivo trans-splicing of 5′ and 3′ segments of pre-mRNA directed by corresponding DNA sequences delivered by gene transfer . Mol Ther . 2003;8:999
  22. Kikumori T , Cote GJ , Gagel RF . Promiscuity of pre-mRNA spliceosome-mediated trans splicing (A problem for gene therapy?) . Hum Gene Ther . 2001;12:1429
  23. Mansfield S , Clark R , Puttaraju M , Kole J , Cohn J , Mitchell L , et al.   5′ Exon replacement and repair by spliceosome-mediated RNA trans-splicing . RNA . 2003;9:1290
  24. Shi Y . Mammalian RNAi for the masses . Trends Genet . 2003;19:9
  25. Tijsterman M , Ketting R , Plasterk R . The genetics of RNA silencing . Ann Rev Genet . 2002;36:489
  26. Hemann M , Fridman J , Zilfou J , Hernando E , Paddison P , Cordon-Cardo C , et al.   An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo . Nat Genet . 2003;33:396
  27. Scherr M , Battmer K , Winkler T , Heidenreich O , Ganser A , Eder M . Specific inhibition of bcr-abl gene expression by small interfering RNA . Blood . 2003;101:1566
  28. Arteaga H , Hinkula J , van Dijk-Hard I , Dilber M , Wahren B , Christensson B , et al.   Choosing CCR5 or Rev siRNA in HIV-1 . Nat Biotechnol . 2003;21:230

PII: S0037-1963(04)00129-5

doi: 10.1053/j.seminhematol.2004.07.006

Seminars in Hematology
Volume 41, Issue 4 , Pages 297-302 , October 2004

Article Tools

* Image Usage & Resolution